“deals” Archives

in
Entry Author Date Location
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More 10/09/20 National
In RNAi Move, Takeda Fronts $300M to Team Up on Arrowhead Liver Drug 10/08/20 National
Federation Bio Bags $50M to Engineer New Approach to Microbiome Drugs 10/06/20 Boston
Bristol Myers to Buy MyoKardia, FDA-Ready Heart Disease Drug for $13.1B 10/05/20 New York
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More 10/02/20 National
Pfizer Pumps $200M Into CStone for Rights to PD-L1 Cancer Drug in China 09/30/20 New York
Orphazyme Stock Sale Reaps $83M as Neimann-Pick Drug Review Begins 09/29/20 Europe
Galecto Picks Up $64M as Plans for Fibrosis Clinical Trials Move Forward 09/25/20 Europe
Bio Roundup: Grail Acquisition, Libra’s Launch, Tau Trial Results & More 09/25/20 National
Monte Rosa Raises $96M for “Glue-Based” Protein Degrading Drugs 09/24/20 Boston
Illumina to Acquire Cancer Diagnostics Developer Grail in $8B Deal 09/21/20 San Francisco
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More 09/18/20 National
Neogene Therapeutics Grabs $110M to Tackle Solid Tumors With Cell Therapy 09/15/20 Europe
Seattle Genetics Lands $1.72B From Merck in Pair of Cancer Drug Deals 09/14/20 Seattle
Gilead Adds “Cornerstone” Cancer Drug in $21B Immunomedics Buyout 09/14/20 San Francisco
Grifols Moves Deeper Into Proteome R&D With $146M Deal for Alkahest 09/08/20 San Francisco
AbbVie Strikes Deal for I-Mab Drug With a Potential Edge in CD47 Chase 09/04/20 National
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally 09/03/20 Boston
Lumen Bioscience Lands $16M to Engineer “Edible” Antibody Drugs 09/02/20 Seattle
Gilead Sciences Places $120M Bet on a Jounce Therapeutics Cancer Drug 09/01/20 San Francisco
Nestlé to Swallow Up Peanut Allergy Drug Maker Aimmune in $2.6B Deal 08/31/20 San Francisco
Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More 08/28/20 National
Acadia Pharma Acquires CerSci, Potential Pain Meds in $52.5M Buyout 08/26/20 San Diego
Yumanity to Merge With Proteostasis to Advance Neuro Drug Pipeline 08/24/20 Boston
J&J Boosts Autoimmune Disease Drug Pipeline With $6.5B Momenta Buyout 08/19/20 New York
Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More 08/14/20 National
F2G Lands $60M for a New Tack on Taking Out Rare Fungal Infections 08/12/20 Europe
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact 08/07/20 Boston
Bio Roundup: A Telehealth Combo, FDA’s BCMA OK, Biogen’s Bet & More 08/07/20 National
As Patients Pivot to Telehealth, Teladoc & Livongo Plan $18.5B Tie-Up 08/05/20 New York
Page 1 of 298 next page »